[1] 龚巍巍,罗胜兰,俞敏.甲状腺癌的流行现况及其危险因素[J].中国预防医学杂志,2013,14(4):317.
[2] 李飞,罗浩军,罗平,等.雌激素受体GPR30、ERα、PR在甲状腺癌组织中的表达及相关性[J].第三军医大学学报,2011,33(16):1691.
[3] VANNUCCHI G,DE LEO S,PERRINO M,et al.Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer[J].Eur J Eendocrinol,2015,173(1):29.
[4] CAINI S,GIBELLI B,PALLI D,et al.Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women:a meta-analysis of prospective studies[J].Cancer Causes Control,2015,26(4):511.
[5] MENG D,WU W,LI Z,et al.Modulates the proliferation and invasion of thyroid cancer cells in response to estrogen[J].Intern J Mol Med,2015,36(2):588.
[6] PUPO M,MAGGIOLINI M,MUSTI AM.GPER mediates non-genomic effects of estrogen[J].Methods Mol Biol,2016,136(6):471.
[7] CYGANKIEWICZ AI,JACENIK D,KRAJEWSKA WM.GPER receptor-the new player in estrogen signaling[J].Postepy Biochem,2015,61(1):52.
[8] CHAMKASEM A,TONITI W.Sequence to structure approach of estrogen receptor alpha and ligand interactions[J].Asian Pac J Cancer Prev,2015,16(6):2161.
[9] JALATI MR,AMIRTOUTI R,DAVATI A.Expression of estrogen and progesterone receptors in papillary thyroid carcinoma[J].Caspian J Intern Med,2016,7(3):183
[10] KUMAR A,KLINGE CM,GOLDSTEIN RE.Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta[J].Int J Oncol,2010,36(5):1067.
[11] WANG S,LIOYD RV,HUTZLER MJ,et al.The role of cell cycle regulatory protein,cyclinD1,in the progression of thyroid cancer[J].Mod Pathol,2000,13(8):882.
[12] CHEN GG,VLANTIS AC,ZENG Q,et al.Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer[J].Curr Cancer Drug Targets,2008,8(5):367.
[13] VIVACQUA A,BONFIGLIO D,ALBANITO L,et al.17β-estradiol,genistein,and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30[J].Mol Pharmacol,2006,70(4):1414.
[14] RAJORIA S,SURIANO R,GEORGE A,et al.Estrogen activity as a preventive and therapeutic target in thyiod cancer[J].Biomed Pharmacother,2012,66(2):151.
[15] ZHANG CM,LI WH,ZHAO XD,et al.Expression and significance of ER and PR in differentiated thyroid carcinoma[J].Chinese-German J Clin Oncol,2014,13(4):149.